Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.
Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM. Collins M, et al. Among authors: herschtal a. J Clin Oncol. 2013 Jun 20;31(18):2303-12. doi: 10.1200/JCO.2012.43.8598. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669227
Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).
Kong G, Thompson M, Collins M, Herschtal A, Hofman MS, Johnston V, Eu P, Michael M, Hicks RJ. Kong G, et al. Among authors: herschtal a. Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1831-44. doi: 10.1007/s00259-014-2788-5. Epub 2014 May 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24844348 Free PMC article.
A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.
Lewin J, Khamly KK, Young RJ, Mitchell C, Hicks RJ, Toner GC, Ngan SY, Chander S, Powell GJ, Herschtal A, Te Marvelde L, Desai J, Choong PF, Stacker SA, Achen MG, Ferris N, Fox S, Slavin J, Thomas DM. Lewin J, et al. Among authors: herschtal a. Br J Cancer. 2014 Dec 9;111(12):2254-61. doi: 10.1038/bjc.2014.537. Epub 2014 Oct 16. Br J Cancer. 2014. PMID: 25321190 Free PMC article. Clinical Trial.
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood.
Liu Z, Martin J, Orme L, Seddon B, Desai J, Nicholls W, Thomson D, Porter D, McCowage G, Underhill C, Cranswick N, Michael M, Zacharin M, Herschtal A, Sivasuthan J, Thomas DM. Liu Z, et al. Among authors: herschtal a. Cancer Chemother Pharmacol. 2018 Nov;82(5):887-898. doi: 10.1007/s00280-018-3683-8. Epub 2018 Sep 11. Cancer Chemother Pharmacol. 2018. PMID: 30206658
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data.
Mac Manus MP, Everitt S, Bayne M, Ball D, Plumridge N, Binns D, Herschtal A, Cruickshank D, Bressel M, Hicks RJ. Mac Manus MP, et al. Among authors: herschtal a. Radiother Oncol. 2013 Mar;106(3):292-8. doi: 10.1016/j.radonc.2012.12.018. Epub 2013 Mar 28. Radiother Oncol. 2013. PMID: 23541364
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.
Everitt S, Ball D, Hicks RJ, Callahan J, Plumridge N, Trinh J, Herschtal A, Kron T, Mac Manus M. Everitt S, et al. Among authors: herschtal a. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):947-955. doi: 10.1016/j.ijrobp.2017.07.035. Epub 2017 Jul 29. Int J Radiat Oncol Biol Phys. 2017. PMID: 29063854
75 results